ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「肥満が脳に炎症を起こし神経変性と関連する仕組み」の検索結果

293 件中 10 件を表示 (3869 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
(obesity[MeSH] OR obese) AND (neuroinflammation OR "brain inflammation") AND (neurodegeneration[MeSH] OR neurodegenerative) AND (mechanism OR pathogenesis OR pathophysiology)

💡 肥満、脳の炎症、神経変性の3要素とメカニズムをANDで結合し、各概念に同義語を追加

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Butyrate ameliorates quinolinic acid-induced cognitive decline in obesity models.

    Xing Ge, Mingxuan Zheng, Minmin Hu 他 · The Journal of clinical investigation · 2023

    Obesity is a risk factor for neurodegenerative disease associated with cognitive dysfunction, including Alzheimer's disease. Low-grade inflammation is common in obesity, but the mechanism between inflammation and cognitive impairment in obesity is unclear. Accumulative evidence shows that quinolinic acid (QA), a neuroinflammatory neurotoxin, is involved in the pathogenesis of neurodegenerative pro…

    📄 PubMed で読む (PMID: 36787221)
  • Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.

    Subbiah Pugazhenthi, Limei Qin, P Hemachandra Reddy 他 · Biochimica et biophysica acta. Molecular basis of disease · 2017

    Cognitive decline in chronic diabetic patients is a less investigated topic. Diabetes and obesity are among the modifiable risk factors for Alzheimer's disease (AD), the most common form of dementia. Studies have identified several overlapping neurodegenerative mechanisms, including oxidative stress, mitochondrial dysfunction, and inflammation that are observed in these disorders. Advanced glycati…

    📄 PubMed で読む (PMID: 27156888)
  • Microglial REV-ERBα regulates inflammation and lipid droplet formation to drive tauopathy in male mice.

    Jiyeon Lee, Julie M Dimitry, Jong Hee Song 他 · Nature communications · 2023

    Alzheimer's disease, the most common age-related neurodegenerative disease, is characterized by tau aggregation and associated with disrupted circadian rhythms and dampened clock gene expression. REV-ERBα is a core circadian clock protein which also serves as a nuclear receptor and transcriptional repressor involved in lipid metabolism and macrophage function. Global REV-ERBα deletion has been sho…

    📄 PubMed で読む (PMID: 37626048)
  • Semaglutide Ameliorates Diabetic Neuropathic Pain by Inhibiting Neuroinflammation in the Spinal Cord.

    Sing-Ong Lee, Yaswanth Kuthati, Wei-Hsiu Huang 他 · Cells · 2024

    Glucagon-like peptide 1 (GLP-1) receptor agonists are frequently used to treat type 2 diabetes and obesity. Despite the development of several drugs for neuropathic pain management, their poor efficacy, tolerance, addiction potential, and side effects limit their usage. Teneligliptin, a DPP-4 inhibitor, has been shown to reduce spinal astrocyte activation and neuropathic pain caused by partial sci…

    📄 PubMed で読む (PMID: 39594606)
  • Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential.

    Renjun Lv, Bin Liu, Ziying Jiang 他 · Metabolism: clinical and experimental · 2025

    Neurodegenerative disorders are straining public health worldwide. During neurodegenerative disease progression, aberrant neuronal network activity, bioenergetic impairment, adaptive neural plasticity impairment, dysregulation of neuronal Ca2+ homeostasis, oxidative stress, and immune inflammation manifest as characteristic pathological changes in the cellular milieu of the brain. There is no drug…

    📄 PubMed で読む (PMID: 39674569)
  • β-glucan attenuates cognitive impairment via the gut-brain axis in diet-induced obese mice.

    Hongli Shi, Yinghua Yu, Danhong Lin 他 · Microbiome · 2020

    "Western" style dietary patterns are characterized by a high proportion of highly processed foods rich in fat and low in fiber. This diet pattern is associated with a myriad of metabolic dysfunctions, including neuroinflammation and cognitive impairment. β-glucan, the major soluble fiber in oat and barley grains, is fermented in the lower gastrointestinal tract, potentially impacting the microbial…

    📄 PubMed で読む (PMID: 33008466)
  • Irisin: A Multifaceted Hormone Bridging Exercise and Disease Pathophysiology.

    Ilaria Paoletti, Roberto Coccurello · International journal of molecular sciences · 2024

    The fibronectin domain-containing protein 5 (FNDC5), or irisin, is an adipo-myokine hormone produced during exercise, which shows therapeutic potential for conditions like metabolic disorders, osteoporosis, sarcopenia, obesity, type 2 diabetes, and neurodegenerative diseases, including Alzheimer's disease (AD). This review explores its potential across various pathophysiological processes that are…

    📄 PubMed で読む (PMID: 39769243)
  • Astrocyte-derived extracellular vesicular NFIA mediates obesity-associated cognitive impairment.

    Lining Wu, Liyun Deng, Xiaolin Xu 他 · Journal of neuroinflammation · 2025

    The escalating global prevalence of cognitive decline associated with obesity represents a significant public health challenge. Emerging evidence implicates astrocyte-derived extracellular vesicles (ADEVs) as key mediators in the pathogenesis of neurodegenerative disease, positioning them as potential therapeutic targets. However, the precise mechanistic role of ADEVs in the pathological processes…

    📄 PubMed で読む (PMID: 40448146)
  • Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19.

    Zhouyi Rong, Hongcheng Mai, Gregor Ebert 他 · Cell host & microbe · 2024

    SARS-CoV-2 infection is associated with long-lasting neurological symptoms, although the underlying mechanisms remain unclear. Using optical clearing and imaging, we observed the accumulation of SARS-CoV-2 spike protein in the skull-meninges-brain axis of human COVID-19 patients, persisting long after viral clearance. Further, biomarkers of neurodegeneration were elevated in the cerebrospinal flui…

    📄 PubMed で読む (PMID: 39615487)
  • Tirzepatide: a novel therapeutic approach for Alzheimer's disease.

    Ghadah H Alshehri, Hayder M Al-Kuraishy, Huda Jaber Waheed 他 · Metabolic brain disease · 2025

    Tirzepatide (TRZ) is a dual agonist of glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptors that were recently approved for the treatment of type 2 diabetes (T2D) and obesity. Of note is that T2D and obesity, by inducing peripheral low-grade inflammation and oxidative stress, provoke the development of central neuroinflammation and oxidative stress. Together, T2D and …

    📄 PubMed で読む (PMID: 40498212)